Clinical trial
Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in…
NCT00188955 · University of Manitoba, Other · Completed
Key facts
| NCT number | NCT00188955 |
|---|---|
| Title | Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant |
| Official title | Phase 4 Randomized, Controlled Study Comparing Sirolimus and Mycophenolate Mofetil to Prevent or Reverse Progression in Pediatric Renal Transplants With Chronic Allograft Nephropathy |
| Lead sponsor | University of Manitoba, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | sirolimus |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| Completion | Oct 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 22, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: